ENTRADA THERAPEUTICS INC (TRDA) Institutional Ownership Changes & 13F Activity

ENTRADA THERAPEUTICS INC (TRDA). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q3 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Baker Bros. Advisors Lp, 5Am Venture Management, Llc, Mpm Bioimpact Llc, Tcg Crossover Management, Llc, and Wellington Management Group Llp.

InstitutionTypeChange in sharesChange Position %SharesReported stock balancePortfolio quarterFiling date
Versant Capital Management, IncSell-16-0.4%4,205$26.70KQ3 2026Oct 02, 2026
State Street CorpSell-596,677-100.0%0$0.00Q3 2026Sep 22, 2026
Manufacturers Life Insurance Company, TheSell-72,520-100.0%0$0.00Q3 2026Sep 09, 2026
Citadel Advisors LlcSell-394,323-100.0%0$0.00Q3 2026Sep 02, 2026
Cornerstone Financial Management LlcSell-91-100.0%0$0.00Q3 2026Aug 28, 2026
California State Teachers Retirement SystemSell-399-100.0%0$0.00Q3 2026Aug 24, 2026
Nantahala Capital Management, LlcSell-300,575-100.0%0$0.00Q3 2026Aug 19, 2026
Cantor Fitzgerald, L. P.Sell-60,000-100.0%0$0.00Q3 2026Aug 19, 2026
Mercer Global Advisors IncSell-20,653-100.0%0$0.00Q3 2026Aug 19, 2026
Public Employees Retirement System Of OhioSell-37,502-100.0%0$0.00Q3 2026Aug 17, 2026
Baker Bros. Advisors LpSell-5,072,730-100.0%0$0.00Q3 2026Aug 14, 2026
5Am Venture Management, LlcSell-4,056,379-100.0%0$0.00Q3 2026Aug 14, 2026
Mpm Bioimpact LlcSell-1,253,053-100.0%0$0.00Q3 2026Aug 14, 2026
Tcg Crossover Management, LlcSell-1,060,230-100.0%0$0.00Q3 2026Aug 14, 2026
Wellington Management Group LlpSell-954,419-100.0%0$0.00Q3 2026Aug 14, 2026
Millennium Management LlcSell-763,959-100.0%0$0.00Q3 2026Aug 14, 2026
Aqr Capital Management LlcSell-699,537-100.0%0$0.00Q3 2026Aug 14, 2026
Price T Rowe Associates IncSell-542,316-100.0%0$0.00Q3 2026Aug 14, 2026
Jacobs Levy Equity Management, IncSell-303,459-100.0%0$0.00Q3 2026Aug 14, 2026
Charles Schwab Investment Management IncSell-197,136-100.0%0$0.00Q3 2026Aug 14, 2026
Longaeva Partners L.P.Sell-195,237-100.0%0$0.00Q3 2026Aug 14, 2026
Goldman Sachs Group IncSell-177,343-100.0%0$0.00Q3 2026Aug 14, 2026
Woodline Partners LpSell-145,600-100.0%0$0.00Q3 2026Aug 14, 2026
Trexquant Investment LpSell-140,143-100.0%0$0.00Q3 2026Aug 14, 2026
Moore Capital Management, LpSell-105,000-100.0%0$0.00Q3 2026Aug 14, 2026
Xtx Topco LtdSell-95,337-100.0%0$0.00Q3 2026Aug 14, 2026
Royce & Associates LpSell-82,902-100.0%0$0.00Q3 2026Aug 14, 2026
Ameriprise Financial IncSell-70,395-100.0%0$0.00Q3 2026Aug 14, 2026
Qube Research & Technologies LtdSell-60,872-100.0%0$0.00Q3 2026Aug 14, 2026
Bank Of America CorpSell-57,927-100.0%0$0.00Q3 2026Aug 14, 2026
Showing 30 of 126

Frequently asked questions about TRDA activity

  • Which institutional owners are buying TRDA?

    Institutional owners buying TRDA include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in TRDA activity?

    "Buy" means an investor increased their reported position in TRDA compared to the prior reporting period. This reflects growing exposure to ENTRADA THERAPEUTICS INC (TRDA) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in TRDA increasing?

    Institutional interest in TRDA can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.